[HTML][HTML] OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive …
C Aghajanian, SV Blank, BA Goff… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2012•ncbi.nlm.nih.gov
Purpose This randomized, multicenter, blinded, placebo-controlled phase III trial tested the
efficacy and safety of bevacizumab (BV) with gemcitabine and carboplatin (GC) compared
with GC in platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer
(ROC).
efficacy and safety of bevacizumab (BV) with gemcitabine and carboplatin (GC) compared
with GC in platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer
(ROC).
Abstract
Purpose
This randomized, multicenter, blinded, placebo-controlled phase III trial tested the efficacy and safety of bevacizumab (BV) with gemcitabine and carboplatin (GC) compared with GC in platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer (ROC).
ncbi.nlm.nih.gov